At the end of 2010, Crid Pharma and Avogadro, two pharmaceutical development companies based in the southwest of France, merged. This group aims to become an integrated player involved in various aspects of drug development (formulation, microbiology, physiochemistry, analytical development, stability studies, quality control, etc.).
Nomen has been commissioned to find a name for this new group.
Amatsi find its origin in the Ewe language, spoken in Ghana and Togo, and means. The word means “medicine” thus anchoring the new identity within the medical sphere.
